Affimed cuts up to 50% of employees to support clinical projects, CEO departs

Af­fimed is slash­ing its head­count by up to half as part of a broad­er re­or­ga­ni­za­tion aimed at sup­port­ing the com­pa­ny through its next round of clin­i­cal mile­stones.

The Ger­man biotech will al­so be look­ing for a new CEO. Adi Hoess is step­ping down ef­fec­tive Jan. 15 af­ter spend­ing 13 years head­ing up Af­fimed. The com­pa­ny has start­ed look­ing for a suc­ces­sor while CMO An­dreas Harstrick will be in­ter­im CEO un­til a new leader is ap­point­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.